Found 98 matching trials
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Melphalan Chemoreduction for Ocular Melanoma PHASE1 The goal of this clinical trial is to investigate a new approach for treati...
Show More Status
Enrolling By Invitation
Location
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP
Learn More & Join Trial
Two Step Haplo With Radiation Conditioning PHASE2 This phase II clinical trial evaluates whether a modified modality of condi...
Show More Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Learn More & Join Trial
Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC PHASE2 This is a single arm, open label, multi-center, phase 2 study to evaluate t...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida
Learn More & Join Trial
STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA PHASE4 Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Show More Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Learn More & Join Trial
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy PHASE3 This study has been designed to evaluate whether "anti-angiogenesis" therap...
Show More Location
University of Arkansas for Medical Sciences/MIRT
Learn More & Join Trial
Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM PHASE1 This study is an investigator-initiated clinical study to evaluate the safe...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation PHASE3 The purpose of this study is to find out if transplant with a new regimen o...
Show More Location
University of Arkansas for Medical Sciences/MIRT
Learn More & Join Trial
Off-the-shelf NK Cells + SCT for Myeloid Malignancies PHASE2 The goal of this clinical research study is to learn about the safety and e...
Show More Location
M D Anderson Caner Center
Learn More & Join Trial